OVERVIEW

Beyond the Scale: The Obesity-Liver Connection is organized by Medical Learning Institute Inc (MLI).

Release Date: Jan 14, 2026
Expiration Date: Jan 13, 2027

Course Details:
This independent satellite symposium, held during the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC), will address the urgent need for clinician education on obesity and its complex, multifactorial relationship with metabolic diseases. Faculty experts will explore the pathophysiological links between obesity and metabolic dysfunction–associated steatotic liver disease (MASLD) and steatohepatitis (MASH), highlight evidence-based strategies for screening and diagnosis, and review emerging therapeutic options. 

Designed for endocrinologists, internists, hepatologists, advanced practice providers, pharmacists, and cardiologists, this activity will equip learners with the knowledge to optimize early detection and integrated management of obesity and obesity-related comorbidities, improving outcomes across diverse patient populations.

Learning Objectives:
After completing this activity, the participant should be better able to:

  • Outline the pathophysiological processes leading to the development of obesity and associated comorbidities including metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction associated steatohepatitis (MASH)
  • Implement evidence-based best practices for screening for and diagnosis of MASLD and MASH in patients with obesity
  • Evaluate new treatment approaches for obesity and MASLD/MASH

Agenda:

  • Welcome and Introduction
  • Pathophysiology of Obesity: Understanding Mechanisms That Modulate Body Weight and Lead to
  • Obesity-Associated Comorbidities
  • The Role of the Liver in Metabolic Disease in Patients with Obesity
  • Emerging Options for Treatment of MASLD/MASH in Patients with Obesity
  • Conclusions and Q+A with Expert Faculty
Credits

This activity is provided by MLI, in collaboration with WCIRDC and MEEF.

Accreditation, Support and Credit
In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).

For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit.

Notice to Diplomates: MLI will report any claimed MOC/Lifelong Learning points to the appropriate Board within 4 weeks of completing the activity. Please ensure that you have provided your Board ID number and MMDD of birth.

PA
Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until January 13, 2027. PAs should only claim credit commensurate with the extent of their participation.

Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour.

Pharmacy 
Medical Learning Institute Inc designates this knowledge-based continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA0007322-0000-26-005-H01-P

For Pharmacists, MLI will accept your completed evaluation form for up to 30 days and will report your participation to the NABP only if you provide your NABP e-Profile number and date of birth. Within 6 weeks, view your participation record at the NABP.

  • 1 AMA PRA Category 1 Credit™
  • 1 AAPA
  • 1 MOC
  • 1 Contact Hours
  • 0.1 CEU
  • 1 IPCE
  • TARGET AUDIENCE

    PhysicianNursingPharmacistPhysician AssistantEndocrinologistsHepatologists

    SPECIALITIES

    CardiologyEndocrinologyInternal Medicine and General MedicineHepatology

    RELATED ONLINE COURSES